Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports

<p>Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Meng-Lan Wang (Autor), Dong-Mei Zhang (Autor), En-Qiang Chen (Autor)
Formato: Livro
Publicado em: Archives of Hepatitis Research - Peertechz Publications, 2017-05-29.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_ahr_000013
042 |a dc 
100 1 0 |a Meng-Lan Wang  |e author 
700 1 0 |a  Dong-Mei Zhang  |e author 
700 1 0 |a En-Qiang Chen  |e author 
245 0 0 |a Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports 
260 |b Archives of Hepatitis Research - Peertechz Publications,   |c 2017-05-29. 
520 |a <p>Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in the drug instruction of ETV. Here we report two CHB patients with ETV-associated constipation in whom symptom fully disappeared following ETV withdrawal.</p> 
540 |a Copyright © Meng-Lan Wang et al. 
546 |a en 
655 7 |a Case Report  |2 local 
856 4 1 |u https://doi.org/10.17352/ahr.000013  |z Connect to this object online.